Beta-blockers (e.g., Carvedilol)
Treatment for Dilated Cardiomyopathy
Typical Dosage: Carvedilol 3.125mg BID up to 25mg BID
Effectiveness
82%
Safety Score
70%
Clinical Trials
1
Participants
70K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Carvedilol 3.125mg BID up to 25mg BID
Time to Effect
4-12 weeks
Treatment Duration
lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
22(Treat 22 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
20(Treat 20 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$700
Side Effect Mgmt:$120
Total Annual:$870
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.9
Outcome-Based Costs
Cost per Responder
$1,243
Cost per Remission
$17,400
Beta-blockers (e.g., Carvedilol) Outcomes
for Dilated Cardiomyopathy
Efficacy Outcomes
Overall Effectiveness
+82%
Response Rate
+70%
Remission Rate
+5%
Common Side Effects
Dizziness
+15%
Fatigue
+15%
Bradycardia
+10%
Hypotension
+10%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov